Abstract:Intracranial germ cell tumours are rare tumours affecting mainly male adolescents, mainly in Asia; here the authors identify frequent mutations in the KIT/RAS and AKT/mTOR signalling pathways as well as rare germline variants in JMJD1C, suggesting potential therapeutic strategies focusing on the inhibition of KIT/RAS activation and the AKT1/mTOR pathway. Relatively little is known about intracranial germ cell tumours (IGCTs) — rare tumours affecting principally male adolescents and mainly in Asia. Using exome sequencing, deep-targeted sequencing and SNP array the authors examined 62 IGCT patients and identified frequent mutations in the KIT/RAS and AKT/mTOR signalling pathways as well as rare germline variants in JMJD1C, a histone demethylase and coactivator of the androgen receptor. This study suggests potential therapeutic strategies focusing on the inhibition of KIT/RAS activation and the AKT1/mTOR pathway. Intracranial germ cell tumours (IGCTs) are a group of rare heterogeneous brain tumours that are clinically and histologically similar to the more common gonadal GCTs. IGCTs show great variation in their geographical and gender distribution, histological composition and treatment outcomes. The incidence of IGCTs is historically five- to eightfold greater in Japan and other East Asian countries than in Western countries1, with peak incidence near the time of puberty2. About half of the tumours are located in the pineal region. The male-to-female incidence ratio is approximately 3–4:1 overall, but is even higher for tumours located in the pineal region3. Owing to the scarcity of tumour specimens available for research, little is currently known about this rare disease. Here we report the analysis of 62 cases by next-generation sequencing, single nucleotide polymorphism array and expression array. We find the KIT/RAS signalling pathway frequently mutated in more than 50% of IGCTs, including novel recurrent somatic mutations in KIT, its downstream mediators KRAS and NRAS, and its negative regulator CBL. Novel somatic alterations in the AKT/mTOR pathway included copy number gains of the AKT1 locus at 14q32.33 in 19% of patients, with corresponding upregulation of AKT1 expression. We identified loss-of-function mutations in BCORL1, a transcriptional co-repressor and tumour suppressor. We report significant enrichment of novel and rare germline variants in JMJD1C, which codes for a histone demethylase and is a coactivator of the androgen receptor, among Japanese IGCT patients. This study establishes a molecular foundation for understanding the biology of IGCTs and suggests potentially promising therapeutic strategies focusing on the inhibition of KIT/RAS activation and the AKT1/mTOR pathway.

Update on MRI in Pediatric Intracranial Germ Cell Tumors—the Clinical and Radiological Features

Recent advances in molecular biology and treatment strategies for intracranial germ cell tumors

Advances in genetic abnormalities, epigenetic reprogramming, and immune landscape of intracranial germ cell tumors

Novel molecular subtypes of intracranial germ cell tumors expand therapeutic opportunities

Pathogenesis of central nervous system germ cell tumors

Intracranial Germ Cell Tumors in Pediatric and Adolescent Patients in China: Systematic Review and Meta-Analysis

Clinical and imaging features of intracranial germinomas in children and teenagers

Intracranial germ cell tumors: a view of the endocrinologist

Grading System for Diagnosis and Treatment of Intracranial Nongerminomatous Malignant Germ Cell Tumors

Extracranial Germ Cell Tumors in Children: Ten Years of Experience in Three Children's Medical Centers in Shanghai

Extracranial Germ Cell Tumors in Children: Ten Years of Experience in Three Children’s Medical Centers in Shanghai

Abstract PR04: Novel somatic and germline mutations in intracranial germ cell tumors

A deep learning model for differentiating paediatric intracranial germ cell tumour subtypes and predicting survival with MRI: a multicentre prospective study

Treatment and Prognosis of Intracranial Germ Cell Tumor

Epid-36. Clinical Features Of 614 Primary Intracranial Germ Cell Tumors: An 15-Year Experience Of A Single Center In China

The Treatment and Prognosis of Primary Pediatric Intracranial Nongerminomatous Malignant Germ Cell Tumors

Biomarkers for risk-based treatment modifications for CNS germ cell tumors: Updates on biological underpinnings, clinical trials, and future directions

Unusual imaging findings associated with abdominal pediatric germ cell tumors

Novel somatic and germline mutations in intracranial germ cell tumours

Whole‐exome sequencing has revealed novel genetic characteristics in intracranial germ cell tumours in the Chinese

Recent advances in understanding the etiology and pathogenesis of pediatric germ cell tumors